# Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders

> **NCT06554873** · PHASE3 · COMPLETED · sponsor: **Rose Research Center, LLC** · enrollment: 150 (actual)

## Conditions studied

- Smoking Cessation
- Harm Reduction

## Interventions

- **DRUG:** Nicoderm
- **DRUG:** Nicorette 4Mg Chewing Gum
- **DRUG:** Nicorette Lozenge Product
- **OTHER:** NJOY e-cigarette
- **OTHER:** on!

## Key facts

- **NCT ID:** NCT06554873
- **Lead sponsor:** Rose Research Center, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-29
- **Primary completion:** 2025-12-09
- **Final completion:** 2025-12-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06554873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06554873, "Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT06554873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*